← Mechanisms of action
IL1B
SINGLE PROTEINHomo sapiens
Preferred name: Interleukin-1 beta ChEMBL ↗
Linked proteins
Drugs acting on this target (16)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ak114 | Antagonist | experimental | mAb | IL1B |
| anakinra (Kineret) | Antagonist | approved | Recombinant protein | IL1B antagonist |
| avtx-009 | Antagonist | experimental | mAb | IL1B antagonist |
| ssgj-613 | Antagonist | experimental | mAb | IL1B |
| cyt013-il1bqb | Immunity, active | experimental | Vaccine | IL1B immunity, active |
| abt-981 | Immunity, passive | experimental | mAb | IL1B immunity, passive |
| abt-981 | Inhibitor | experimental | mAb | Interleukin-1 beta inhibitor |
| canakinumab (ilaris) | Inhibitor | approved | mAb | IL1B inhibitor |
| cdp-484 | Inhibitor | experimental | mAb | IL1B inhibitor |
| fl-101 | Inhibitor | experimental | Small molecule | IL1B inhibitor |
| gevokizumab | Inhibitor | experimental | mAb | IL1B inhibitor |
| Goflikicept | Inhibitor | experimental | Small molecule | IL1B inhibitor |
| ly2189102 | Inhibitor | experimental | mAb | IL1B inhibitor |
| rilonacept (arcalyst) | Inhibitor | approved | Recombinant protein | IL1B inhibitor |
| zenuzolac | Inhibitor | experimental | Small molecule | IL1B inhibitor |
| gevokizumab | Negative allosteric modulator | experimental | mAb | IL1B negative allosteric modulator |